Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04962815 · ClinicalTrials.gov registry record
Ceribell Delirium Data Collection Study
A clinical trial of Delirium, sponsored by Ceribell.
- Recruiting
- Registry status
- 200
- Enrollment target
- 7
- Study locations
NCT04962815: Recruiting study of Delirium, sponsored by Ceribell.
NCT04962815 is a study of Delirium that is actively recruiting participants, run by Ceribell. The registered enrollment target is 200 participants, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (77% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04962815, a study of Delirium, is actively recruiting participants, sponsored by Ceribell.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.
Primary Outcome
Research coordinator will perform and collect CAM-ICU assessment data on study subjects
Conditions Studied
Interventions
- DEVICE Electroencephalogram (EEG) Test
Study Locations (7)
California
- Stanford University - Stanford
Florida
- Naples Community Hospital - Naples
Iowa
- University of Iowa Hospitals & Clinics - Iowa City
Missouri
- Mercy - St Louis
New Jersey
- Cooper Health - Camden
North Carolina
- UNC Health Rex - Raleigh
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2026-04-01 |
What NCT04962815 shows while recruiting
NCT04962815 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Electroencephalogram (EEG) Test is the first listed.
NCT04962815 lists 7 locations in 7 states (California, Florida, Iowa).
Frequently Asked Questions
What is clinical trial NCT04962815 about?
NCT04962815 is a clinical study titled "Ceribell Delirium Data Collection Study". This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the...
What is the current status of trial NCT04962815?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-11-10. Estimated completion is 2026-04-01.
What conditions does trial NCT04962815 study?
This clinical trial studies the following conditions: Delirium.
What interventions are being tested in trial NCT04962815?
The interventions under investigation include: Electroencephalogram (EEG) Test (DEVICE).
Who is sponsoring clinical trial NCT04962815?
This trial is sponsored by Ceribell, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04962815 being conducted?
This trial has 7 study locations across California, Florida, Iowa, Missouri, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04962815's enrollment target sits among peer trials
200 30th of 62 higher than 32 of 62 other Delirium trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI